Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Renhe Pharmacy Pays $46 Million for Two Pharma Acquisitions

publication date: Apr 26, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Renhe Pharmacy, a company that makes OTC drug products including treatments for cold and flu, will spend 288 million RMB ($46 million) to acquire two smaller China drugmakers: Jiangxi Yaodu Zhangshu Pharmacy and Jiangxi Yaodu Pharmacy. Renhe purchased the two companies from their corporate parent, Jiangxi Yaodu Pharmacy Group. More details....

Stock Symbol: (SHE: 000650)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors